No black box warning on record for Fabrazyme
As of the latest FDA labeling reviewed, Fabrazyme (AGALSIDASE BETA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Fabrazyme medicine page for the complete safety profile.